Mosaic stock has lagged over the past three years even as the broader valuation checks now lean cheap, which puts the recent rebound in a different light for anyone trying to price the next phase. The shares carry a high value score and screen as undervalued on market multiples, yet the long stretch of weak returns still raises questions about what the market is worried about.
For investors, the debate is whether Mosaic's current share price already reflects the cautious three year track record or if the high value score hints at mispriced potential.
Scan beyond Mosaic and size up other potential deep value rebound stories through 49 high quality undervalued stocks while this pocket of the market is still pricing in cautious three year track records.
The P/S ratio suits Mosaic because the business is heavily tied to commodity cycles where profits can swing more than revenue. On sales, the stock trades on a P/S of 0.7x, which is below both the chemicals industry average of 1.1x and the peer group near 1.3x. The implied fair P/S ratio from the model is 0.9x, so the current level sits below what would be expected once revenue profile, size and risk inputs are taken into account.
Despite the fresh attention around the Uberaba rare earths work, the market is still pricing Mosaic at a discount to the fair P/S benchmark and to sector norms. If the business simply sustains its current revenue base rather than needing outsized expansion, that kind of gap can matter more than headline earnings volatility.
On the preferred P/S multiple, Mosaic appears undervalued relative to both its tailored fair ratio and the wider chemicals industry.
See what the numbers say about this price — find out in our valuation breakdown.
Narratives pick up where Mosaic's valuation puzzle leaves off by spelling out which future paths for growth, margins and earnings would need to play out for the stock to merit a meaningfully higher or lower price than today, using the Community page as the home for those scenarios. Each one ties its number to a specific view on where Mosaic's growth, profitability and risk profile could head next, which gives you something concrete to test as fresh information comes through.
Mosaic investors are effectively weighing two very different playbooks, with community narratives split between a long runway for margin repair and a much harsher read on future cost pressure.
Bull case: 23% undervalued
"Analysts broadly agree that expanded potash and phosphate capacity, plus increased market access in Brazil, will boost revenues. The ongoing global supply constraints, minimal new industry capacity until at least 2027, and Mosaic's aggressive production ramp create the potential for outsized revenue growth and margin expansion as the company captures elevated prices and pent-up demand…"
Read the full Bull Case to see why Mosaic could be undervalued
Bear case: 47% overvalued
"Increasing global requirements for sustainable agricultural practices are expected to trigger more rigorous environmental regulations in major markets. This will likely elevate operational costs for Mosaic through higher compliance expenses, additional capex for process changes, and possible regulatory penalties, severely impacting long-term net margins and constraining profitability…"
Read the full Bear Case to see why Mosaic could be overvalued
Do you think there's more to the story for Mosaic? Head over to our Community to see what others are saying!
Mosaic screens as undervalued on its preferred P/S yardstick, which flags a clear discount to both tailored fair ratios and sector norms. Broader valuation checks also lean supportive, so the debate now turns less on whether the stock is cheap and more on why that gap exists. The key question is whether margins and returns can stabilise enough for that multiple to move closer to peers, or whether concerns around execution and regulatory cost keep the shares parked in value trap territory.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com